The present invention is directed to a therapeutic support device that is configured to assist in the minimization of decubitus ulcers (that is, pressure ulcers) and methods of using same. The device can include one or more sets of support pins disposed on one or more corresponding load bars. Each load bar can be disposed on a corresponding inflatable bladder. The bladders can be inflated and deflated to raise and lower the corresponding load bars and pins. In operation, a user sits or lies on the therapeutic device and air or another fluid is admitted to and discharged from the bladders to respectively increase and decrease pressure applied by the device to the user's body. The pressure in individual bladders also can be changed in a manner enabling the pins to massage the patient and promote localized capillary and lymphatic blood flow. The level of control the device provides for pressure relief and massaging can be increased by increasing the number of bladders and/or zones and/or by adjusting the manner in which an associated control system regulates inflation and deflation of the bladders.
The device can be placed on a bed, operating table, imaging device, or other surface to provide pressure relief to a patient lying thereon. It may replace a mattress, pillow, or pad or it may be placed on top of a mattress, pillow, or pad. It may also be used with chairs, wheelchairs, and other load-bearing devices on which a user may be disposed for long periods of time.
The attached drawings are part of the specification and represent certain embodiments of the present invention as well as their component parts. The components in the drawings are not necessarily to scale, emphasis instead being placed upon illustrating the principles of the present invention.
Elongated pins 106A, 106B rest on or are connected to load bars 104A, 104B, and load bars 104A, 104B rest on or are connected to bladders 102A, 102B. Load bars 104A, 104B serve to distribute loads applied to elongated pins 106A, 106B across bladders 102A, 102B and vice versa. Although load bars 104A, 104B could be omitted, the omission thereof would result in the loads applied to elongated pins 106A, 106B to be concentrated against corresponding points of bladders 102A, 102B, which could result in the need for bladders 102A, 102B to be operated at relatively higher pressures.
As
As
Also like top stand-off 108, center stand-off 116 includes a plurality of channels 200B formed by pairs of vertical walls 300B extending downward therefrom. Each of channels 200B is configured to slidably receive a corresponding load bar 104B. The top surface of center stand-off 116 is substantially flat and supports bladders 102A of upper portion “A” of bladder-pin device 100, as well as top stand-off 108. Center stand-off 116 is configured to be disposed between top stand-off 108 and base plate 114. Top stand-off 108 is attached to center stand-off 116 and center stand-off 116 is attached to base plate 114 using fasteners 202A, 202B, which may be screws or rivets. Alternatively, those components may be attached via any other suitable means, for example, vibration welding. Bladders 102A, 102B are aligned and held in place on base plate 114 and center stand-off 116 with alignment pins 118A, 118B installed on the base plate 114 and center stand-off 116.
As
In the second and third configurations, cylindrical base portion 302 can have a diameter slightly larger than the width of the thin part of the “T” (see, for example,
In both the second and third configurations, additional clearance can be provided between guide groove 500 and cylindrical openings 604 so elongated pins 106A, 106B can “float” a small amount in the guide groove 500 or cylindrical opening 604. That is, elongated pins 106A, 106B can slide in guide groove 500 in the longitudinal direction and have float in the vertical and lateral directions, and elongated pins 106A and 106B in cylindrical openings 604 can float in all three directions. The floating effect provided by this additional clearance allows elongated pins 106A, 106B to be more easily aligned and inserted through openings 112A, 112B in top stand-off 108 and center stand-off 116 during assembly of bladder-pin device 100. Moreover, the provision of at least one degree of movement for elongated pins 106A, 106B in the second and third configurations reduces the likelihood that the moving parts of the bladder-pin device 100 will bind during use, thereby potentially increasing its durability. The additional clearance provided in guide groove 500 and cylindrical openings 604 is preferably about 0.5 mm in each direction, although greater or lesser amounts of clearance may be provided as desired to facilitate the smooth assembly and operation of bladder-pin device 100.
Alternatively, elongated pins 106A, 106B may be attached to load bars 104A, 104B using any suitable mechanical connection or adhesive. Springs (not shown) may also be provided to hold elongated pins 106A, 106B in contact with load bars 104A, 104B. Such springs could bear against base portions 302 of elongated pins 106A, 106B and corresponding portions of top stand-off 108 or center stand-off 116. Load bars 104A, 104B may also be formed with any combination of the features illustrated in
Bladder-pin device 100 may also use a combination of different types of load bars 104A, 104B. For example, lower portion “B” of bladder-pin device 100 can be provided with load bars 104B illustrated in
In
When load bars 104A, 104B slide within channels 200A, 200B formed in top stand-off 108 and center stand-off 116, they apply a force to each elongated pin 106A, 106B being supported by corresponding bladder 102A and 102B with which the load is being applied. By constraining the movement of each load bar 104A, 104B to be axial with respect to elongated pins 106A, 106B, guiding protrusions 404 increase stability. Thus, load bars 104A, 104B can provide linear, simultaneous, and consistent actuation of elongated pins 106A, 106B.
As
Each bladder 102A, 102B includes an inflatable region 700 defined by seams 702 where an upper layer 704 and lower layer 706 of bladder material are fused together. The bladder material may be any suitable flexible material, such as rubber. Upper layer 704 can be fused to lower layer 706 using, for example, RF welding such that seams 702 are defined by the corresponding weld boundaries. Inflatable region 700 of each bladder 102A, 102B can be approximately the same width as a load bar 104A, 104B, as illustrated in
As
The use of inflatable bladders 102A, 102B to achieve that functionality provides a robust, non-caustic, low noise, and low cost mechanism for actuating elongated pins 106A, 106B. Although alternate mechanisms could be used for causing linear travel of elongated pins 106A, 106B, such mechanisms could be more costly, heavier, and likely to introduce contaminants into a hospital or other controlled setting in the event of maintenance or failure. Bladders 102A, 102B may be pneumatically or hydraulically actuated.
Elongated pins 106B provided in lower portion “B” are longer than elongated pins 106A provided in upper portion “A” so they can extend through both lower portion “B” and upper portion “A” and protrude from upper-most surface 110 of bladder-pin device 100. Elongated pins 106A, 106B move between actuated and non-actuated positions when bladders 102A, 102B are inflated and deflated, respectively. In the actuated position, elongated pins 106A, 106B extend a sufficient distance—preferably between 7.5 mm and 15 mm or a greater or lesser distance based on the application—from upper-most surface 110 of bladder-pin device 100 to provide focused pressure at the tips of elongated pins 106A, 106B. In the non-actuated position, elongated pins 106A, 106B may be substantially flush with the upper-most surface 110 of bladder-pin device 100, or may extend preferably 2 mm or less from the upper-most surface 110. Alternatively, in the non-actuated condition, elongated pins 106A, 106B may extend other distances (for example, 0 mm, 7.5 mm, or 15 mm) from upper-most surface 110 or be recessed within top stand-off 108. Accordingly, the length of elongated pins 106B provided in lower portion “B” should be sufficiently great that they can extend the same distance from upper-most surface 110 of bladder-pin device 100 as elongated pins 106A of upper portion “A” when those pins are in the actuated position.
Elongated pins 106A, 106B are particularly suited for supporting a user's weight while not diminishing subcutaneous blood flow between the pin contact points, thereby potentially reducing the likelihood of formation of a decubitus ulcer. To achieve that result, elongated pins 106A, 106B preferably have a diameter of about 8 mm, are spaced approximately 20 to 25 mm apart from each other. It is believed that such dimensions would yield a device that can maintain contact pressure in the interstices between the pins in contact with the user's body at about 26 to 32 mm Hg or less. (The contact pressure between pins in contact with the user's body could be as low as zero where that portion of the body is suspended between such pins or it could be higher than zero due to a hammocking effect in applications where a liner or sheet is disposed between device 100 and the user's skin.) Other dimensions and greater or lesser pressure may be provided as desired for particular applications and to accommodate certain parameters, such as the weight of the patient being supported. In an illustrative embodiment, bladder-pin device 100 can distribute weights of up to 400 pounds or more.
Elongated pins 106A, 106B may be of the type disclosed in, for example, U.S. Pat. Nos. 6,241,695, 6,383,153, 6,689,077, and 7,037,278, the disclosures of which are hereby incorporated by reference. Elongated pins 106A, 106B can be formed either of a single rigid material or a dual durometer material with soft tips for additional patient comfort. Elongated pins 106A, 106B can also be spring loaded to create a self leveling effect that matches a patient's various contours. Also, cam systems could be employed to further vary or control the pin movement.
In operation, different ones of elongated pins 106A, 106B can be actuated by inflating corresponding bladders 102A, 102B. As bladders 102A, 102B are inflated, inflatable regions 700 increase in diameter or thickness. Bladders 102A, 102B are trapped within channels 200A and 200B of top stand-off 108 and center stand-off 116, respectively, wherein load bars 104A, 104B rest on top of bladders 102A, 102B. When bladders 102A, 102B increase in diameter or thickness, they raise load bars 104A, 104B. Elongated pins 106A, 106B are attached on top of load bars 104A, 104B and extend from upper-most surface 110 of top stand-off 108 as load bars 104A, 104B are raised. When bladders 102A, 102B are deflated, load bars 104A, 104B return to their original depressed position, allowing elongated pins 106A, 106B to retract back into top stand-off 108. When moving between the non-actuated, depressed position to the actuated, inflated position, elongated pins 106A, 106B preferably travel 10 mm or more, but can travel greater or lesser distances depending on the application. Vacuum means and/or springs (for example, springs between top stand-off 108 and center stand-off 116 and their respective load bars 104A and 104B) may be provided and/or load bars 104A, 104B may be affixed to bladders 102A, 102B to assist in returning load bars 104A, 104B and elongated pins 106A, 106B to their original positions as bladders 102A, 102B are deflated.
Bladders 102A and 102B can be inflated in areas of the bladder-pin device 100 that correspond to a particular area of a user's body so that corresponding pins 106A, 106B can provide support to that area of the user's body. In this way, a user's weight in that area can be evenly distributed across actuated elongated pins 106A, 106B to preserve subcutaneous blood flow around areas of the body between such pins 106A, 106B. Subcutaneous blood flow could be further preserved, and perhaps even promoted, by actuating elongated pins 106A, 106B in a massaging pattern. For example, in the embodiments illustrated
When bladder-pin device 100 is assembled as a single-level device, the density of the pin configuration can be maintained by providing rows of non-moving, static pins 1300 between rows of bladders 102 and load bars 104. As
As
The inclusion of static pins 1300 in rows between bladders 102 and load bars 104 that extend and lower elongated pins 106, allows the single-level bladder-pin device 100 to provide the same or a similar density of pins as a multi-level bladder-pin device 100. It also allows for the same or similar functionality for preserving and promoting subcutaneous blood flow in the interstices between elongated pins 106 as well as between the static pins 1300. For example, by inflating and deflating the bladders 102 in an alternating and progressive pattern, an oscillating, wave-like pattern of movement can be created across the elongated pins 106 and static pins 1300, wherein static pins 1300 support the affected area on a patient's body in a location where a bladder 102 is deflated, and wherein elongated pins 106 support the affected area on a patient's body in the location where a bladder 102 is inflated. In that way, the single-level bladder-pin device 100 can massage an affected area on a patient's body and encourage localized capillary and lymphatic blood flow. Similar therapeutic effects may also be achieved by inflating and deflating the bladders 102 in unison with each other so that focused pressure is provided to the affected area on a patient's body in an alternating manner by the static pins 1300 and the elongated pins 106. If that alternating pattern is all that is required in a certain application, all of the elongated pins 106 can be provided on a single load plate 1500 rather than on a plurality of separate load bars 104.
As
As
In yet another embodiment of the single-level bladder-pin device 100, all of static pins 1300 can be raised and lowered in unison instead of raising and lowering elongated pins 106 in unison. As
Bladders 102A and 102B can be provided in a pad 3200 (see
PCU 2204 includes an electronic control unit (ECU) that is controlled by UIC 2202. Via UIC 2202, a user can modify the timing and sequencing of the ECU to program the actuation and dwell of bladders 102A and 102B, which allows the user to define countless patterns and cycles in which pins 106A and 106B are actuated/inflated. As illustrated in
Turning to
Although user interface panel 2300 is described above as providing for only three specific different, predefined patterns and cycles of inflation/deflation, user interface panel 2300 and UIC 2202 could be adapted to allow a user to define, store, and actuate any number of other patterns and cycles of inflation/deflation as well as for full manual operation of which bladders 102A and 102B are deflated and inflated. UIC 2202 provides the main point of input from the doctor, nurse, or patient and controls the patterns and cycles of inflation/deflation by controlling solenoids that open and close regulator valves 2208 and dump valves 2210. It also controls pressure regulators that determine the pressures in the bladders 102A and 102B as well as operation of the pneumatic pump 2206. UIC 2202 can also be programmed to monitor, control, and collect data from sensors that examine load, pressure, temperature, and moisture, with or without respect to time.
The operation of UIC 2202 and PCU 2204 are preferably implemented by any suitable computing processor or processing platform that is capable of performing the functions and operations in accordance with the invention. Each of those devices may include a user interface and/or display for operating the computing processor or processing platform. All or parts of the system and processes can be stored on or read from a memory or computer readable media.
UIC 2202, PCU 2204, and pneumatic pump 2206 may be battery powered (VDC) or wall outlet powered (VAC). In operation, therapeutic device 2200 and its various components preferably, but not necessarily, maintain a noise level lower than 40 dB and can cycle a 400 pound load at least 10,000 times. Preferably but not necessarily, the maximum current draw of each component is 5 amps.
In addition to the components disclosed above, system 2200 may also include a double thickness liner bag 3100 (
Liner bag 3100 assists in patient comfort and protects the patient-supporting components of system 2200 while allowing smooth actuation of elongated pins 106 and/or static pins 1300. Accordingly, liner bag 3100 is specifically designed to allow for slip between layers that provide low friction across its surfaces as well as elasticity so as to not impair the performance of pin-bladder devices 100 housed therein. Also, liner bag 3100 stretches in a manner that allows for the patient's weight to be supported by the elongated pins 106 and/or static pins 1300 without the bag being ripped or torn. Liner bag 3100 is also impervious to various fluids so as to protect the patient-supporting components of system 2200 against the ingress of foreign matter, such as urine, feces, blood, and alcohol. It can be used more than once because it can be removed and cleaned, and it can also be cleaned without being removed using inflatable side bladders 3204 to pull the surface of liner bag 3100 tight.
Liner bag 3100 includes sealing grommets 3102 that allow pneumatic lines 2220 to be connected between inflatable bladders 102A, 102B, and/or 3204 and pneumatic pump 2206; a non-slip bottom layer 3104 and straps (not shown) that hold the device securely to the table, bed, or medical imaging device on which it is being used; an inner protective layer 3106 for protecting the patient-supporting components within the liner bag 3100 and preventing the liner bag 3100 from ripping or tearing; and a stretchable outer layer 3108 that stretches as the elongated pins 106 and/or static pins 1300 press against the liner bag 3100. Non-slip bottom layer 3104 is preferably a fabric that holds up strongly to wear and abrasion while also offering grip and non-skid in both wet and dry conditions, such as the SLIP-NOT brand fabric made by Eastex Products, Inc.; inner protective layer 3106 is preferably a nylon-reinforced rip-stop material; stretchable outer layer 3108 is preferably a fluid-proof and stain-resistant fabric that stretches in the two directions perpendicular to the plane of the fabric, such as the TEK STRETCH 2 brand fabric made by Eastex Products, Inc.; and the strap is preferably made of nylon and can preferably support a 200 pound retention load. Liner bag 3100 may also include an inner slip/shear reducer 3110 disposed between the non-slip bottom layer 3104 and the inner protective layer 3106 to reduce slip/shear between those layers.
Inflatable side bladders 3204 can be inflated as part a cleaning mode for the liner bag 3100. The cleaning mode stretches the liner bag 3100 to remove any wrinkles or folds from it so that the entire external surface of the liner bag 3100 can be more easily cleaned. Side bladder 3204 can also incorporate a secondary chamber to provide a dynamic edge rail 3206.
Alternatively, dynamic edge rail could be a separate structure attached to side bladder 3204, device 100 or a related component. Dynamic edge rail 3206 can comprise a fourth inflatable zone that can be inflated or deflated as desired, for example, to provide side bolstering for a patient. Alternatively, dynamic edge rail 3206 can be formed from a durable soft material that is attached at the sides of the bladder-pin device 100. Additional inflatable structures could be provided in the form of pillows or other support devices. System 2200 could be adapted to control the inflation and deflation of these additional inflatable structures.
As an alternative to forming therapeutic device 100 in the shape of the load-bearing device on which it will be used, therapeutic device 100 can be made in a standard, modular configuration and disposed in a foam insert 3300 that is formed in the shape of the load-bearing device on which therapeutic device 100 will be used. Thus, instead of making different several therapeutic devices 100 to conform to the shape of different load bearing devices, foam insert 3300 can be formed to the shape of different load-bearing devices. It is easier and less costly to modify the shape of the foam insert 3300 for each different load-bearing device than to modify therapeutic devices 100. Foam insert 3300 is preferably made from a medium density medical grade cellular urethane foam, such as the PORON brand foam made by Stockwell Elastomerics, Inc. Different and/or additional materials may also be used to construct the liner bag 3100 depending on the application and the desired attributes of the liner bag 3100.
As illustrated in
Each of bladders 102A, 102B may be provided with means, for example, a one-time programmable (OTP) chip including the bladder's serial number, for self-identification when connected to a control system, as well as means, for example, an erasable programmable memory (EPROM) for storing other information relevant to the bladder, for example, the number of inflation/deflation cycles it has been subjected to. The control system could be configured to not operate a bladder if the control system does not recognize the bladder's serial number or if it determines that the bladder has been used for an excessive number of cycles.
Additional advantages and modifications will readily occur to those skilled in the art. Therefore, the invention in its broader aspects is not limited to the specific details and representative embodiments shown and described herein. Accordingly, various modifications may be made without departing from the spirit or scope of the general inventive concept as defined by the appended claims and their equivalents.
The present application claims priority from U.S. Provisional Application Ser. No. 61/350,842, filed Jun. 2, 2010, and U.S. Provisional Application Ser. No. 61/390,016, filed Oct. 5, 2010, the disclosures of which are hereby incorporated by reference.
Number | Name | Date | Kind |
---|---|---|---|
1274851 | Bybd | Aug 1918 | A |
2604758 | Swindler | Jul 1952 | A |
2719986 | Rand | Oct 1955 | A |
3148391 | Whitney | Sep 1964 | A |
3199124 | Grant | Aug 1965 | A |
3303518 | Ingram | Feb 1967 | A |
3390674 | Jones | Jul 1968 | A |
3483862 | Takeuchi | Dec 1969 | A |
3674019 | Grant | Jul 1972 | A |
3678520 | Evans | Jul 1972 | A |
3701173 | Whitney | Oct 1972 | A |
3784994 | Kery | Jan 1974 | A |
3919730 | Regan et al. | Nov 1975 | A |
3970077 | Dahl | Jul 1976 | A |
4037591 | Sarno | Jul 1977 | A |
4175297 | Robbins et al. | Nov 1979 | A |
4267611 | Aguinick | May 1981 | A |
4391009 | Schild et al. | Jul 1983 | A |
4472847 | Gammons et al. | Sep 1984 | A |
4524762 | Schulman | Jun 1985 | A |
4559656 | Foster | Dec 1985 | A |
4653130 | Senoue et al. | Mar 1987 | A |
4799276 | Kadish | Jan 1989 | A |
4840425 | Noble | Jun 1989 | A |
D315188 | Thomas | Mar 1991 | S |
4999861 | Huang | Mar 1991 | A |
5010608 | Barnett et al. | Apr 1991 | A |
5035016 | Mori et al. | Jul 1991 | A |
5060326 | Oswald | Oct 1991 | A |
5103518 | Gilroy et al. | Apr 1992 | A |
5109558 | Di Blasi | May 1992 | A |
5117518 | Schild | Jun 1992 | A |
5135282 | Pappers | Aug 1992 | A |
5210889 | Wesemann et al. | May 1993 | A |
5235710 | Nagashima | Aug 1993 | A |
5243723 | Cotner | Sep 1993 | A |
D341983 | Wang | Dec 1993 | S |
5267365 | Walter | Dec 1993 | A |
5437068 | Fisher | Aug 1995 | A |
5447491 | Bellandi | Sep 1995 | A |
5487196 | Wilkinson et al. | Jan 1996 | A |
5542136 | Tappel | Aug 1996 | A |
5659910 | Weiss | Aug 1997 | A |
5678265 | Meyer | Oct 1997 | A |
5685036 | Kopfstein et al. | Nov 1997 | A |
5687438 | Biggie et al. | Nov 1997 | A |
5729853 | Thompson | Mar 1998 | A |
5755000 | Thompson | May 1998 | A |
5820573 | Ramos | Oct 1998 | A |
5901393 | Pepe et al. | May 1999 | A |
5963997 | Hagopian | Oct 1999 | A |
5970550 | Gazes | Oct 1999 | A |
6014784 | Taylor et al. | Jan 2000 | A |
6098222 | Hand et al. | Aug 2000 | A |
6151740 | Morimoto | Nov 2000 | A |
6178578 | Soltani et al. | Jan 2001 | B1 |
6216299 | Kohlman | Apr 2001 | B1 |
6241695 | Dabir | Jun 2001 | B1 |
6336907 | Dono et al. | Jan 2002 | B1 |
6378152 | Washburn et al. | Apr 2002 | B1 |
6383153 | Dabir | May 2002 | B2 |
D471051 | Cook | Mar 2003 | S |
D474061 | Cook et al. | May 2003 | S |
6668405 | Kohlman | Dec 2003 | B1 |
6687935 | Reeder et al. | Feb 2004 | B2 |
6689077 | Dabir | Feb 2004 | B2 |
6711771 | Cook et al. | Mar 2004 | B2 |
D490635 | Boso | Jun 2004 | S |
6823549 | Hampton et al. | Nov 2004 | B1 |
6829797 | Partian | Dec 2004 | B2 |
6910238 | Biggie et al. | Jun 2005 | B2 |
6912749 | Thomas et al. | Jul 2005 | B2 |
7037278 | Dabir | May 2006 | B2 |
7159255 | Piraino | Jan 2007 | B2 |
D537287 | Lau | Feb 2007 | S |
7191482 | Romano et al. | Mar 2007 | B2 |
7328472 | Chaffee | Feb 2008 | B2 |
7392557 | Kohlman | Jul 2008 | B1 |
7409735 | Kramer et al. | Aug 2008 | B2 |
7520011 | Liberkowski | Apr 2009 | B1 |
7562409 | Chan | Jul 2009 | B2 |
7740015 | Hyde et al. | Jun 2010 | B2 |
7784130 | Pile | Aug 2010 | B2 |
7789086 | Hyde et al. | Sep 2010 | B2 |
8215311 | Hyde et al. | Jul 2012 | B2 |
20020133105 | Dabir | Sep 2002 | A1 |
20040231051 | Jansen | Nov 2004 | A1 |
20060117488 | Hung et al. | Jun 2006 | A1 |
20060150327 | Jansen | Jul 2006 | A1 |
20060217645 | Lockamy | Sep 2006 | A1 |
20070033738 | Tu | Feb 2007 | A1 |
20080034501 | Hyde et al. | Feb 2008 | A1 |
20080035156 | Hyde et al. | Feb 2008 | A1 |
20080040861 | Ootayopas | Feb 2008 | A1 |
20080178392 | Chu | Jul 2008 | A1 |
20080188781 | Carkner et al. | Aug 2008 | A1 |
20090193590 | Hata | Aug 2009 | A1 |
20100024132 | Carlson et al. | Feb 2010 | A1 |
20100205750 | McCausland et al. | Aug 2010 | A1 |
20100218315 | Hyde et al. | Sep 2010 | A1 |
20100263131 | Kajiwara et al. | Oct 2010 | A1 |
20110107521 | Alder et al. | May 2011 | A1 |
20120060294 | Dzioba et al. | Mar 2012 | A1 |
Number | Date | Country |
---|---|---|
4201460 | Jul 1993 | DE |
0025701 | Mar 1981 | EP |
2107197 | Apr 1983 | GB |
2197192 | May 1988 | GB |
03022197 | Mar 2003 | WO |
2004096108 | Nov 2004 | WO |
Entry |
---|
International Search Report and Written Opinion for Int'l Pat. Appl. No. PCT/US2011/038928, dated Nov. 11, 2011. |
International Search Report and Written Opinion for Int'l Pat. Appl. No. PCT/US2011/054982, dated Jan. 18, 2012. |
Number | Date | Country | |
---|---|---|---|
20120060294 A1 | Mar 2012 | US |
Number | Date | Country | |
---|---|---|---|
61350842 | Jun 2010 | US | |
61390016 | Oct 2010 | US |